| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8667747 | Journal of Cardiac Failure | 2018 | 35 Pages |
Abstract
These results suggest that teneligliptin prevents concentric LV hypertrophy, fibrosis, and development of congestive heart failure in Dahl salt-sensitive rats. Teneligliptin may inhibit pressure-overload hypertrophic adaption and result in LV eccentric hypertrophy with reduced LV ejection fraction.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Masayoshi MD, PhD, Tomoko MD, PhD, Yoshihiro MD, PhD, Yoshimi MD, PhD, Seika MD, Dongzhu MD, PhD, Nobuyuki MD, PhD, Taizo MD, PhD, Yasushi MD, PhD, Kazutaka MD, PhD,